STAT+: Novo underwhelmed by drug it once fought Pfizer for

Revolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech news
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

Revolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech news
Source
Stat News
Opens original article in a new tab

The biggest U.S. health insurer is changing how it pays for lactation counseling, and it could cut payment for many providers.

(MedPage Today) -- Note that some links may require registration or subscription. Harvard University professor Robert Coles, MD, the psychiatrist and Pulitzer Prize-winning author who championed the cause of children grappling with poverty and...

Lilly disclosed new data that provide more details on the safety and tolerability of its next-generation obesity drug retatrutide

Johnson & Johnson said it will purchase the startup Firefly Bio for $1 billion in an effort to expand its work in the suddenly buzzy field of KRAS inhibitors.